By using gravity/gauge correspondence, we employ an Einstein-Maxwell-Dilaton model to compute the equilibrium and out-of-equilibrium properties of a hot and baryon rich strongly coupled quark-gluon plasma. The family of 5-dimensional holographic black holes, which are constrained to mimic the lattice QCD equation of state at zero density, is used to investigate the temperature and baryon chemical potential dependence of the equation of state. We also obtained the baryon charge conductivity, and the bulk and shear viscosities with a particular focus on the behavior of these observables on top of the critical end point and the line of first order phase transition predicted by the model.
One of the fundamental signatures of the Quark Gluon Plasma has been the suppression of heavy flavor (specifically D mesons), which has been measured via the nuclear modification factor, RAA
and azimuthal anisotropies, vn
, in large systems. However, multiple competing models can reproduce the same data for RAA
to vn
. In this talk we break down the competing effects that conspire together to successfully reproduce RAA
and vn
in experimental data using Trento+v-USPhydro+DAB-MOD. Then using our best fit model we make predictions for RAA
and vn
across system size for 208PbPb, 129XeXe, 40ArAr, and 16OO collisions. We find that 0–10% centrality has a non-trivial interplay between the system size and eccentricities such that system size effects are masked in v2 whereas in 30–50% centrality the eccentricities are approximately constant across system size and, therefore, is a better centrality class to study D meson dynamics across system size.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.